U.S. Markets open in 7 hrs 51 mins
  • S&P Futures

    3,253.00
    -49.25 (-1.49%)
     
  • Dow Futures

    26,189.00
    -368.00 (-1.39%)
     
  • Nasdaq Futures

    11,129.00
    -213.75 (-1.88%)
     
  • Russell 2000 Futures

    1,536.50
    -21.90 (-1.41%)
     
  • Crude Oil

    35.93
    -0.24 (-0.66%)
     
  • Gold

    1,873.10
    +5.10 (+0.27%)
     
  • Silver

    23.45
    +0.09 (+0.39%)
     
  • EUR/USD

    1.1681
    +0.0003 (+0.0234%)
     
  • 10-Yr Bond

    0.8350
    0.0000 (0.00%)
     
  • Vix

    37.59
    -2.69 (-6.68%)
     
  • GBP/USD

    1.2905
    -0.0018 (-0.1407%)
     
  • USD/JPY

    104.2140
    -0.3960 (-0.3786%)
     
  • BTC-USD

    13,349.85
    -137.38 (-1.02%)
     
  • CMC Crypto 200

    261.59
    +18.91 (+7.79%)
     
  • FTSE 100

    5,581.75
    -1.05 (-0.02%)
     
  • Nikkei 225

    23,052.65
    -279.29 (-1.20%)
     

Xtant Medical to Issue Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on March 5, 2020

BELGRADE, Mont., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2019, before the open of the financial markets on Thursday, March 5, 2020.

Sean Browne, President and Chief Executive Officer, and Greg Jensen, Vice President, Finance and Chief Financial Officer, will host a conference call on Thursday, March 5 at 9:00 AM ET to review results.

Conference Details
Conference Date: Thursday, March 5, 2020 - 9:00 AM ET
Conference dial-in: 877-407-6184
International dial-in: 201-389-0877
Conference Call Name: Xtant Medical Fourth Quarter 2019 Financial Results
Webcast Registration: Click Here

Following the live call, a replay will be available on the Company’s website, www.xtantmedical.com, under “Investor Info.”

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

Investor Relations Contact

David Carey
Lazar FINN Partners
Ph: 212-867-1762
Email: david.carey@finnpartners.com